AMICUS THERAPEUTICS

amicus-therapeutics-logo

Amicus Therapeutics (Nasdaq:FOLD) is a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases. The Company has a robust pipeline of novel, first-in-class, small molecules called pharmacological chaperones for the treatment of lysosomal storage diseases (LSDs). These chaperones may offer a dual-treatment approach for Fabry, Pompe, Gaucher and other LSDs. As orally administered monotherapy agents, pharmacological chaperones are designed to bind to, stabilize and increase the activity of a patientโ€™s own misfolded enzyme. In combination with enzyme replacement therapy (ERT), pharmacological chaperones may improve the uptake of the infused enzyme and potentially improve ERT outcomes.

#SimilarOrganizations #People #Financial #Website #More

AMICUS THERAPEUTICS

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2002-01-01

Address:
Cranbury, New Jersey, United States

Country:
United States

Website Url:
http://www.amicusrx.com

Total Employee:
501+

Status:
Active

Contact:
(609)662-200

Email Addresses:
[email protected]

Total Funding:
843.05 M USD

Technology used in webpage:
LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Domain Not Resolving Euro Amazon IPv6 JsDelivr


Similar Organizations

agile-therapeutics-logo

Agile Therapeutics

Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

koya-medical-logo

Koya Medical

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

munogenics-logo

Munogenics

Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers in both humans and animals.

iveric-bio-logo

IVERIC bio

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

not_available_image

Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

vigeo-therapeutics-logo

Vigeo Therapeutics

Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.


Current Advisors List

sol-barer_image

Sol Barer Member of the Board of Directors @ Amicus Therapeutics
Board_member

stephen-bloch_image

Stephen Bloch Board Member @ Amicus Therapeutics
Board_member

m-james-barrett_image

M. James Barrett Board Member @ Amicus Therapeutics
Board_member

james-topper_image

James Topper Board Member @ Amicus Therapeutics
Board_member

mike-raab_image

Mike Raab Board Member @ Amicus Therapeutics
Board_member

Current Employees Featured

john-crowley_image

John Crowley
John Crowley Executive Chairman @ Amicus Therapeutics
Executive Chairman
2005-01-01

jayne-gershkowitz_image

Jayne Gershkowitz
Jayne Gershkowitz Chief Patient Advocate @ Amicus Therapeutics
Chief Patient Advocate
2016-05-01

bradley-l-campbell_image

Bradley L. Campbell
Bradley L. Campbell President & Chief Executive Officer @ Amicus Therapeutics
President & Chief Executive Officer
2006-01-01

jayne-gershkowitz_image

Jayne Gershkowitz
Jayne Gershkowitz Senior Vice President & Chief Patient Advocate @ Amicus Therapeutics
Senior Vice President & Chief Patient Advocate
2015-05-01

hung-do_image

Hung Do
Hung Do Chief Science Officer @ Amicus Therapeutics
Chief Science Officer
2015-06-01

david-clark_image

David Clark
David Clark Chief People Officer @ Amicus Therapeutics
Chief People Officer
2018-10-01

jay-barth_image

Jay Barth
Jay Barth Chief Medical Officer @ Amicus Therapeutics
Chief Medical Officer
2014-03-01

alex-fell_image

Alex Fell
Alex Fell Head Ethics, Compliance and DPO International @ Amicus Therapeutics
Head Ethics, Compliance and DPO International
2020-07-01

jayne-gershkowitz_image

Jayne Gershkowitz
Jayne Gershkowitz Vice President, Patient Advocacy & Public Policy @ Amicus Therapeutics
Vice President, Patient Advocacy & Public Policy
2013-01-01

enrique-dilonรฉ_image

Enrique Dilonรฉ
Enrique Dilonรฉ Vice President @ Amicus Therapeutics
Vice President

Founder


john-crowley_image

John Crowley

Stock Details


Company's stock symbol is NASDAQ:FOLD

Acquisitions List

Date Company Article Price
2018-09-20 Celenex Celenex acquired by Amicus Therapeutics 452 M USD
2015-08-31 Scioderm Scioderm acquired by Amicus Therapeutics 847 M USD
2013-11-01 Callidus Biopharma Callidus Biopharma acquired by Amicus Therapeutics N/A

Investors List

hayfin-capital-management_image

Hayfin Capital Management

Hayfin Capital Management investment in Post-IPO Debt - Amicus Therapeutics

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - Amicus Therapeutics

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Amicus Therapeutics

midcap-financial_image

MidCap Financial

MidCap Financial investment in Post-IPO Debt - Amicus Therapeutics

glaxosmithkline_image

GlaxoSmithKline

GlaxoSmithKline investment in Post-IPO Equity - Amicus Therapeutics

muscular-dystrophy-association_image

Muscular Dystrophy Association

Muscular Dystrophy Association investment in Grant - Amicus Therapeutics

the-michael-j-fox-foundation_image

Michael J. Fox Foundation

Michael J. Fox Foundation investment in Grant - Amicus Therapeutics

prospect-venture-partners_image

Prospect Venture Partners

Prospect Venture Partners investment in Series D - Amicus Therapeutics

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series D - Amicus Therapeutics

chl-medical-partners_image

CHL Medical Partners

CHL Medical Partners investment in Series D - Amicus Therapeutics

Official Site Inspections

http://www.amicusrx.com Semrush global rank: 936.1 K Semrush visits lastest month: 38.33 K

  • Host name: amicus-ws1.embercloud.io
  • IP address: 44.196.157.127
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Amicus Therapeutics" on Search Engine